BCBS South Carolina Medical Policy Updates – January 2019

Click here to view the Blue Cross Blue Shield South Carolina Medical Policy Updates »

January 2019 BCBS South Carolina Medical Policy Updates:

• Adoptive Immunotherapy
• Air Fluidized Beds
• Allogeneic Pancreas Transplant
• Angelchik™ Anti-Reflux Prosthesis
• Arthroscopic Debridement and Lavage as Treatment for Osteoarthritis of the Knee
• Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
• Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
• Axial Lumbosacral Interbody Fusion
• Balloon Dilation of the Eustachian Tube
• Bariatric Surgery
• Bone Morphogenetic Protein
• BRAF Gene Mutation Testing To Select Melanoma Patients for BRAF Inhibitor Targeted Therapy
• BRINEURA (cerliponase alfa)
• Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
• Cardiovascular Disease Risk Assessment
• Cervical Cancer Screening Technologies with Pap and HPV
• Continuous Passive Motion (CPM) in the Home Setting
• Contrast Enhanced Computed Tomography Angiography (CTA) for Coronary Artery Evaluation
• Deep Brain Stimulation
• Dermatologic Applications of Photodynamic Therapy
• Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome
• Donor Leukocyte Infusion for Hematologic Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant
• Durable Medical Equipment (DME)
• Electromagnetic Navigation Bronchoscopy
• Enhanced External Counterpulsation (EECP)
• Enteral Feeding In-Line Cartridge (EFIC™)/Immobilized Lipase Cartridge/Relizorb™ä
• Eteplirsen for Duchenne Muscular Dystrophy
• Eye Movement Desensitization and Reprocessing (EMDR) Therapy
• Ferritin Testing
• Gait Analysis
• Gender Reassignment Surgery
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
• General Genetic Testing, Germline Disorders
• General Genetic Testing, Somatic Disorders
• Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
• Genetic Testing for CHARGE Syndrome
• Genetic Testing for Familial Cutaneous Malignant Melanoma
• Genetic Testing for Fanconi Anemia
• Genetic Testing for FMR1 mutations (including Fragile X Syndrome)
• Genetic Testing for Germline Mutations of the RET Proto-Oncogene in Medullary Carcinoma of the Thyroid
• Genetic Testing for Hereditary Breast and/or Ovarian Cancer Syndrome (BRCA1/BRCA2)
• Genetic Testing for Hereditary Hemochromatosis
• Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment
• Genetic Testing for Rett Syndrome
• Genetic Testing of CADASIL Syndrome
• Genetic Testing of Mitochondrial Disorders
• Golimumab (Simponi)
• High-Sensitivity C-Reactive Protein and Peripheral Arterial Tonometry
• Home Uterine Activity Monitoring
• Homocystinuria
• Hypothermia to Prevent/Reduce Hair Loss During Chemotherapy
• Implantable Bone Conduction and Bone Anchored Hearing Aids
• Implantation of Intrastromal Corneal Ring Segments
• Interferential Current Stimulation
• Intracardiac Ischemia Monitoring
• Intraoperative Radiotherapy
• Isolated Limb Perfusion/Infusion for Malignant Melanoma
• Keratoprosthesis
• Kidney Transplant
• Knee Braces, Orthopaedic Casts, Splints
• Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients With Cancer
• Leadless Cardiac Pacemaker
• Lipid Panels
• Liver Transplant
• Medical Policy Development and Review
• Microwave Tumor Ablation
• Minimally Invasive Hip and Knee Arthroplasty
• MRI of the Breast
• Noninvasive Prenatal Screening for Fetal Aneuploidies Using Cell-Free Fetal DNA
• Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease
• Octreotide Acetate (Sandostatin)
• Oncologic Applications of Interleukin-2 (Aldesleukin) When Used as Monotherapy
• Oncologic uses of Interferon Therapy
• Outpatient Pulmonary Rehabilitation
• Pathogen Panel Testing
• Percutaneous Intradiscal Electrothermal (IDET) Annuloplasty and Percutaneous Intradiscal Radiofrequency Annuloplasty
• Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines
• Photodynamic Therapy for Choroidal Neovascularization
• Prenatal Genetic and Chromosomal Metabolic Testing
• Prenatal Screening
• Preventive Services for Non Grandfathered (PPACA) Plans: Immunizations
• Preventive Services for Non-Grandfathered (PPACA) Plans: USPSTF recommended services
• Progesterone Therapy as a Technique to Reduce Preterm Delivery in High-Risk Pregnancies
• Radiation Oncology Services
• Renflexis™ (infliximab-abda)
• Responsive Neurostimulation for the Treatment of Refractory Partial Epilepsy
• Rituximab
• Sacroiliac Joint Fusion or Stabilization
• Small Bowel/Liver and Multivisceral Transplant
• Stimulation of the Sacral Anterior Root Combined with Posterior Sacral Rhizotomy in Patients with Spinal Cord Injury
• Subtalar Arthroereisis and Subtalar Joint Implant
• Suprachoroidal Delivery of Pharmacologc Agents
• Surgical and Ablative Treatments for Chronic Headaches
• Surgical Treatment of Chest Wall Deformities (Congenital or Acquired)
• Telemedicine
• Testosterone Testing
• Thyroid Disease Testing
• Topographic Brain Mapping
• Total Ankle Replacement
• Transcranial Magnetic Stimulation for Depression and Other Neuropsychiatric Disorders
• Treatment of Twin-Twin Transfusion Syndrome with Amnioreduction and/or Fetoscopic Laser Therapy
• Treatment of Varicose Veins/Venous Insufficiency
• Vacuum-Assisted Breast Biopsy
• Vagus Nerve Stimulation
• Vitamin B12 and Methylmalonic Acid Testing
• Vitamin D Testing
• Zika Virus Risk Assessment
• Balloon Dilatation of Prostate
• Diagnostic Testing of Most Common Sexually Transmitted Infections
• Genetic Testing for Duchenne, Becker, Facioscapulohumeral, and Limb-Girdle Muscular Dystrophies
• Incapacitated Dependent Coverage

Click here to view the Blue Cross Blue Shield South Carolina Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.